Ultragenyx Pharmaceutical (RARE) Other Working Capital Changes: 2016-2025
Historic Other Working Capital Changes for Ultragenyx Pharmaceutical (RARE) over the last 10 years, with Sep 2025 value amounting to -$9.9 million.
- Ultragenyx Pharmaceutical's Other Working Capital Changes rose 22.12% to -$9.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $7.8 million, marking a year-over-year increase of 170.83%. This contributed to the annual value of -$11.7 million for FY2024, which is 23.45% up from last year.
- As of Q3 2025, Ultragenyx Pharmaceutical's Other Working Capital Changes stood at -$9.9 million, which was down 3,064.54% from -$313,000 recorded in Q2 2025.
- In the past 5 years, Ultragenyx Pharmaceutical's Other Working Capital Changes ranged from a high of $22.5 million in Q4 2021 and a low of -$12.7 million during Q3 2024.
- Its 3-year average for Other Working Capital Changes is -$1.8 million, with a median of -$313,000 in 2025.
- Per our database at Business Quant, Ultragenyx Pharmaceutical's Other Working Capital Changes surged by 1,062.45% in 2022 and then crashed by 1,362.62% in 2024.
- Ultragenyx Pharmaceutical's Other Working Capital Changes (Quarterly) stood at $22.5 million in 2021, then tumbled by 114.38% to -$3.2 million in 2022, then spiked by 138.86% to $1.3 million in 2023, then tumbled by 57.27% to $538,000 in 2024, then rose by 22.12% to -$9.9 million in 2025.
- Its last three reported values are -$9.9 million in Q3 2025, -$313,000 for Q2 2025, and $17.5 million during Q1 2025.